Dissecting the immune cell landscape in hepatocellular carcinoma—are we understanding complexity?
Author(s) -
Matthias Ocker
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.03.170
Subject(s) - hepatocellular carcinoma , immune system , cancer research , medicine , computational biology , biology , immunology
Charité University Medicine Berlin, Berlin, Germany; Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany Correspondence to: Prof. Dr. Matthias Ocker. Charité University Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany. Email: matthias.ocker@charite.de. Provenance: This is an invited article commissioned by the Guest Section Editor Dr. Rui Liao (Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China). Comment on: Tang X, Shu Z, Zhang W, et al. Clinical significance of the immune cell landscape in hepatocellular carcinoma patients with different degrees of fibrosis. Ann Transl Med 2019;7:528.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom